Login / Signup

Blood n-3 fatty acid levels and total and cause-specific mortality from 17 prospective studies.

William S HarrisNathan L TintleFumiaki ImamuraFrank QianAndres V Ardisson KoratMatti MarklundLuc DjousséJulie K BassettPierre-Hugues CarmichaelYun-Yu ChenYoichiro HirakawaLeanne K KüpersFederica LaguzziMaria LankinenRachel A MurphyCécilia SamieriMackenzie K SennPeilin ShiJykri K VirtanenIngeborg A BrouwerKuo-Liong ChienGudny EiriksdottirNita G ForouhiJohanna Marianna GeleijnseGraham G GilesVilmundur G GudnasonCatherine HelmerAllison M HodgeRebecca JacksonKay-Tee KhawMarkku LaaksoHeidi LaiDanielle LaurinKarin LeanderJoan LindsayRenata MichaJaako MursuToshiharu NinomiyaWendy PostBruce M PsatyUlf RisérusJennifer G RobinsonAladdin H ShadyabLinda SnetselaarAleix Sala-VilaYangbo SunLyn M SteffenMichael Y TsaiNicholas J WarehamAlexis C WoodJason H Y WuFrank HuFrank B HuDavid S SiscovickRozenn N LemaitreDariush Mozaffariannull null
Published in: Nature communications (2021)
The health effects of omega-3 fatty acids have been controversial. Here we report the results of a de novo pooled analysis conducted with data from 17 prospective cohort studies examining the associations between blood omega-3 fatty acid levels and risk for all-cause mortality. Over a median of 16 years of follow-up, 15,720 deaths occurred among 42,466 individuals. We found that, after multivariable adjustment for relevant risk factors, risk for death from all causes was significantly lower (by 15-18%, at least p < 0.003) in the highest vs the lowest quintile for circulating long chain (20-22 carbon) omega-3 fatty acids (eicosapentaenoic, docosapentaenoic, and docosahexaenoic acids). Similar relationships were seen for death from cardiovascular disease, cancer and other causes. No associations were seen with the 18-carbon omega-3, alpha-linolenic acid. These findings suggest that higher circulating levels of marine n-3 PUFA are associated with a lower risk of premature death.
Keyphrases